Skip to main content
. 2024 Apr 11;25(8):4232. doi: 10.3390/ijms25084232
ABI ankle–brachial index
ADT androgen deprivation therapy
AHA American Heart Association
AMI acute myocardial infarction
ASCVD atherosclerotic cardiovascular disease
BAC breast arterial calcification
BC breast cancer
CAC coronary artery calcium
CAD coronary artery disease
CHIP clonal hematopoiesis of indeterminate potential
CT computed tomography
CCTA coronary computed tomography angiography
CTA computed tomography angiography
cTnT cardiac troponin T
CV cardiovascular
CVD cardiovascular disease
CVRFs cardiovascular risk factors
DAMPs danger-associated molecular patterns
EAT epicardial adipose tissue
EC endothelial cell
FAI Fat Attenuation Index
GDF-15 growth differentiation factor-15
GnRH gonadotropin releasing hormone
GWAS genome wide association studies
HDL high-density lipoprotein
HF heart failure
HR hazard ratio
hs-CRP high-sensitivity C-reactive protein
GOF gain of function
ICI immune checkpoint inhibitor
IL interleukin
LDL-C low-density lipoprotein
LOF loss of function
Lp(a) lipoprotein(a)
MACE major adverse CV event
MCP-1 monocyte chemoattractant protein-1
M1 M1 macrophage
M2 M2 macrophage
MRI magnetic resonance imaging
NAFLD non-alcoholic fatty liver disease
NET neutrophil extracellular trap
NK natural killer
NLRP3 nucleotide oligomerization domain-containing, leucine-rich repeat-containing, and pyrin domain-containing protein3
NSCLC non-small-cell lung cancer
PESA Progression of Early Subclinical Atherosclerosis
PET positron emission tomography
PlGF placental growth factor
PMNs polymorphonuclear neutrophils
PVAT perivascular adipose tissue
RCT randomized controlled trial
ROS reactive oxygen species
ST2 suppression of tumorigenicity 2
Th2 type 2 helper T cells
TG triglycerides
T reg regulatory T cells
TNF-α tumor necrosis factor-α
VEGF vascular endothelial growth factor